Gyors elérés
Tagok linkjei
Páciensek linkjei
Kategóriák
Plazmagyűjtés
Tudjon meg többet a plazmagyűjtésről és találja meg az Önhöz legközelebb található tanúsított plazmaközpontot.
Páciensek forrásai
Iratkozzon fel a plazmafehérje-terápiás iparág magazinjára és tudjon meg még több érdekességet.
Plazma kezelések
Tudjon meg többet arról, hogy miért bírnak a terápiás kezelések ekkora jelentős értékkel a betegek számára.
Plazma GYIK
Kérdéseit tegye fel nyugodtan itt, vagy keressen válaszokat a plazma terápiák folyamatáról és az adományozási eljárásokról.
Érdekképviselet
Learn more about the Association's advocacy efforts to ensure patient access to therapies.
Hozzáférhetőség
Ismerje meg a főbb problémákat régiónként, hogy minél jobban tudja támogatni a terápiákhoz való hozzáférést.
Blogbejegyzések
Szakértői cikkek, elemzések és friss iparági nézőpontok a plazmafehérje-terápiák világából.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Jun 1, 2018
The Source summer 2018
Magazine of the plasma protein therapeutics industry - Summer 2018
All
The Source Magazine
https://cdn.prod.website-files.com/638f893112c6eac0e46ac576/644fcd8265fce21b20a6ec45_Source_Summer%202018.pdf
Jun 1, 2018
The Source summer 2018
Magazine of the plasma protein therapeutics industry - Summer 2018
All
The Source Magazine
https://cdn.prod.website-files.com/638f893112c6eac0e46ac576/644fcd8265fce21b20a6ec45_Source_Summer%202018.pdf
Apr 1, 2018
Frequent source plasma donors are not at risk of iron depletion: the Ferritin Levels in Plasma Donor (FLIPD) study
Whole blood and red blood cell (RBC) donors are at risk of iron deficiency. Since Source plasma (SP) donors have RBCs returned during apheresis, risk of iron depletion appears low. However, SP donors can donate frequently and assessment of frequent donor iron status is needed.
All
Publication
https://pubmed.ncbi.nlm.nih.gov/29520799/
Apr 1, 2018
Frequent source plasma donors are not at risk of iron depletion: the Ferritin Levels in Plasma Donor (FLIPD) study
Whole blood and red blood cell (RBC) donors are at risk of iron deficiency. Since Source plasma (SP) donors have RBCs returned during apheresis, risk of iron depletion appears low. However, SP donors can donate frequently and assessment of frequent donor iron status is needed.
All
Publication
https://pubmed.ncbi.nlm.nih.gov/29520799/
Mar 16, 2018
PPTA Statement on “How Blood-Plasma Companies Target the Poorest Americans”
The article, “How Blood-Plasma Companies Target the Poorest Americans,” by H. Luke Shaefer and Analidis Ochoa, published in The Atlantic on March 15, was unfair to plasma donors as well as to individuals living with rare, genetic, and chronic diseases who rely on access to plasma protein therapies. Plasma donors are due our gratitude and respect, not sweeping negative characterizations.
All
PPTA statements
Mar 16, 2018
PPTA Statement on “How Blood-Plasma Companies Target the Poorest Americans”
The article, “How Blood-Plasma Companies Target the Poorest Americans,” by H. Luke Shaefer and Analidis Ochoa, published in The Atlantic on March 15, was unfair to plasma donors as well as to individuals living with rare, genetic, and chronic diseases who rely on access to plasma protein therapies. Plasma donors are due our gratitude and respect, not sweeping negative characterizations.
All
PPTA statements
Mar 1, 2018
The Source Spring 2018
Magazine of the plasma protein therapeutics industry - Spring 2018
All
The Source Magazine
https://drive.google.com/file/d/1-qXwMdB9LODxAprdsmlCnzrFkR3YPn9H/view?usp=sharing
Mar 1, 2018
The Source Spring 2018
Magazine of the plasma protein therapeutics industry - Spring 2018
All
The Source Magazine
https://drive.google.com/file/d/1-qXwMdB9LODxAprdsmlCnzrFkR3YPn9H/view?usp=sharing
No results found